Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancerOZCELIK, Hilmi; PINNADUWAGE, Dushanthi; BULL, Shelley B et al.Breast cancer research and treatment. 2007, Vol 105, Num 3, pp 255-265, issn 0167-6806, 11 p.Article

PATCHED-ONE or SMOOTHENED Gene Mutations Are Infrequent in Chondrosarcoma : Molecular genetics in sarcomaTAIQIANG YAN; ANGELINI, Mark; ALMAN, Benjamin A et al.Clinical orthopaedics and related research. 2008, Vol 466, Num 9, pp 2184-2189, issn 0009-921X, 6 p.Article

Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent : Evidence from Tissue Microarray Studies on a Lymph Node-Negative CohortMULLIGAN, Anna Marie; PINNADUWAGE, Dushanthi; BULL, Shelley B et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4168-4174, issn 1078-0432, 7 p.Article

p53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancersDONE, Susan J; ARNESON, Nona C. R; ÖZCELIK, Hilmi et al.Breast cancer research and treatment. 2001, Vol 65, Num 2, pp 111-118, issn 0167-6806Article

Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of Breast Cancer at the Ontario site of the Breast Cancer family registryFIGUEIREDO, Jane C; KNIGHT, Julia A; BRIOLLAIS, Laurent et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 4, pp 583-591, issn 1055-9965, 9 p.Article

Insights From Mixture Cure Modeling of Molecular Markers for Prognosis in Breast CancerYILMAZ, Yildiz E; LAWLESS, Jerald F; ANDRULIS, Irene L et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 2047-2054, issn 0732-183X, 8 p.Article

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breastDONE, Susan J; ESKANDARIAN, Sasha; BULL, Shelley et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 9, pp 700-704, issn 0027-8874Article

EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family RegistryBANE, Anita L; MULLIGAN, Anna Marie; PINNADUWAGE, Dushanthi et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 831-839, issn 0167-6806, 9 p.Article

LAF-4 is aberrantly expressed in human breast cancerTO, Minh D; FASERUK, Stephanie A; GOKGOZ, Nalan et al.International journal of cancer. 2005, Vol 115, Num 4, pp 568-574, issn 0020-7136, 7 p.Article

Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the breast cancer family registryKNIGHT, Julia A; ONAY, U. Venus; WELLS, Sean et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 1, pp 146-149, issn 1055-9965, 4 p.Article

Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancerFORSE, Catherine L; YILMAZ, Yildiz E; PINNADUWAGE, Dushanthi et al.Breast cancer research and treatment. 2013, Vol 137, Num 3, pp 709-719, issn 0167-6806, 11 p.Article

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcomaGOKGOZ, Nalan; WUNDER, Jay S; MOUSSES, Spyro et al.Cancer. 2001, Vol 92, Num 8, pp 2181-2189, issn 0008-543XArticle

Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation CarriersJOHN, Esther M; MCGUIRE, Valerie; TERRY, Mary Beth et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 9, pp 1547-1556, issn 1055-9965, 10 p.Article

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyREBBECK, Timothy R; ANTONIOU, Antonis C; GREENE, Mark H et al.Breast cancer research and treatment. 2009, Vol 115, Num 1, pp 185-192, issn 0167-6806, 8 p.Article

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarraysBANE, Anita L; BECK, Jeanne C; JOHN, Esther M et al.The American journal of surgical pathology. 2007, Vol 31, Num 1, pp 121-128, issn 0147-5185, 8 p.Article

Medical radiation exposure and breast cancer risk: Findings from the Breast Cancer family registryJOHN, Esther M; PHIPPS, Amanda I; WHITTEMORE, Alice S et al.International journal of cancer. 2007, Vol 121, Num 2, pp 386-394, issn 0020-7136, 9 p.Article

No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 yearsMCGUIRE, Valerie; JOHN, Esther M; TERRY, Mary Beth et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 8, pp 1565-1567, issn 1055-9965, 3 p.Article

The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersSPURDLE, Amanda B; ANTONIOU, Antonis C; SOUTHEY, Melissa C et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 1, pp 76-79, issn 1055-9965, 4 p.Article

CK8/18 Expression, the Basal Phenotype, and Family History in Identifying BRCA1-Associated Breast Cancer in the Ontario Site of the Breast Cancer Family RegistryMULLIGAN, Anna Marie; PINNADUWAGE, Dushanthi; BANE, Anita L et al.Cancer. 2011, Vol 117, Num 7, pp 1350-1359, issn 0008-543X, 10 p.Article

Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer RegistryMARIE MULLIGAN, Anna; RAITMAN, Irene; FEELEY, Linda et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 336-346, issn 1078-0432, 11 p.Article

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersCOUCH, Fergus J; GAUDET, Mia M; MCGUFFOG, Lesley et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 4, pp 645-657, issn 1055-9965, 13 p.Article

CHEK2^*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer―Specific Death, and Increased Risk of a Second Breast CancerWEISCHER, Maren; NORDESTGAARD, Børge G; DEVILEE, Peter et al.Journal of clinical oncology. 2012, Vol 30, Num 35, pp 4308-4316, issn 0732-183X, 9 p.Article

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersCOX, David G; SIMARD, Jacques; SZABO, Csilla et al.Human molecular genetics (Print). 2011, Vol 20, Num 23, pp 4732-4747, issn 0964-6906, 16 p.Article

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast CancerTAVTIGIAN, Sean V; OEFNER, Peter J; FEUCHTINGER, Corinna et al.American journal of human genetics. 2009, Vol 85, Num 4, pp 427-446, issn 0002-9297, 20 p.Article

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesisBARSYTE-LOVEJOY, Dalia; LAU, Suzanne K; BOUTROS, Paul C et al.Cancer research (Baltimore). 2006, Vol 66, Num 10, pp 5330-5337, issn 0008-5472, 8 p.Article